ロード中...
Pharmacological considerations in the design of anti-malarial drug combination therapies – is matching half-lives enough?
Anti-malarial drugs are now mainly deployed as combination therapy (CT), primarily as a mechanism to prevent or slow the spread of resistance. This strategy is justified by mathematical arguments that generally assume that drug ‘resistance’ is a binary all-or-nothing genetic trait. Herein, a pharmac...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3975950/ https://ncbi.nlm.nih.gov/pubmed/24552440 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2875-13-62 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|